|
Apr 18
|
We Think Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Can Afford To Drive Business Growth
|
|
Mar 13
|
Corbus Pharmaceuticals (CRBP) Upgraded to Buy: Here's What You Should Know
|
|
Mar 11
|
Corbus Pharmaceuticals: Q4 Earnings Snapshot
|
|
Mar 11
|
Corbus Pharmaceuticals Reports Q4 and 2024 Financial Results and Provides a Corporate Update
|
|
Feb 14
|
Corbus Pharmaceuticals Highlights Data From Its First US-Based Trial Of Lead Cancer Drug Candidate
|
|
Feb 14
|
CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting ADC Demonstrates Encouraging Safety and Broader Efficacy in Phase 1 Study in the US and UK Presented at ASCO-GU 2025
|
|
Feb 11
|
Corbus Pharmaceuticals Announces Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at 2025 ASCO-GU
|
|
Nov 26
|
Corbus Pharmaceuticals Holdings, Inc. (CRBP): An Oversold Healthcare Stock to Invest In Now
|
|
Nov 12
|
Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference
|
|
Oct 3
|
Is Corbus Pharmaceuticals Holdings, Inc. (CRBP) the Best Russell 2000 Stock to Buy According to Analysts?
|
|
Aug 28
|
Corbus Pharmaceuticals Holdings, Inc. (CRBP): One of Oppenheimer’s Top Stock Picks For the Next 12 Months
|
|
Aug 26
|
Wall Street Analysts Think Corbus Pharmaceuticals (CRBP) Could Surge 43.82%: Read This Before Placing a Bet
|
|
Jul 30
|
Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences in August
|
|
Jun 1
|
SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical Update Presented at ASCO 2024
|
|
May 30
|
Corbus Pharmaceuticals to Present at the 45th Annual Goldman Sachs Global Healthcare Conference
|
|
May 23
|
Updated Phase 1 Clinical Data for SYS-6002 (CRB-701) to be presented at 2024 ASCO Annual Meeting
|
|
May 9
|
Corbus Pharmaceuticals to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
|
|
May 7
|
Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
|
|
May 1
|
Corbus Pharmaceuticals to Participate in the BTIG Obesity Health Forum
|
|
Apr 24
|
Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting
|